The Nuclear Medicine group was established in early 2021 due to the support of the Sêr Cymru programme, and supports Welsh ambitions for a medical radionuclide production facility in the region.
Our research is focused primarily in two areas:
1. The applications of radionuclides in diagnostic and therapeutic applications, particularly in novel areas such as Auger or proton capture therapy.
2. The production, extraction and transport of medical radionuclides.